Cameron M. Armstrong

Author

University of California, Davis ORCID

Also Known As

Cameron Armstrong, Cameron Armstrong*, Cameron M Armstrong, Cameron M. Armstrong

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of California, Davis VA Northern California Health Care System West China Hospital of Sichuan University Sichuan University UC Davis Comprehensive Cancer Center

About

Cameron M. Armstrong is an author at University of California, Davis specializing in medicine, oncology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	334
2	Cell Biology	2	2	60
3	Endocrinology	2	2	156
4	Arts	1	1	35
5	Gastroenterology	1	1	41

Cameron M. Armstrong

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma Guangxi Sun, Junru Chen, Jiayu Liang, Nature Communications	2021	155
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer Chengfei Liu, Wei Lou, Joy C. Yang, Nature Communications	2018	121
Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer Chengfei Liu, Cameron M. Armstrong, Wei Lou, Molecular Cancer Therapeutics PharmacotherapyCancer BiologyAbiraterone TherapyMolecular PharmacologyTranscriptional Regulation	2016	115
Integrated Molecular Characterization of Fumarate Hydratase–deficient Renal Cell Carcinoma Guangxi Sun, Xingming Zhang, Jiayu Liang, Clinical Cancer Research	2021	104
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition Chengfei Liu, Wei Lou, Cameron M. Armstrong, The Prostate	2015	103
Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer Chengfei Liu, Cameron M. Armstrong, Yezi Zhu, Oncotarget	2016	101
Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategies. Cameron M. Armstrong, Allen C. Gao PubMed Molecular PharmacologyAndrogen ReceptorUrologyOncologyHormone-sensitive Prostate Cancer	2015	96
Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer Jinge Zhao, Shu Ning, Wei Lou, Molecular Cancer Therapeutics	2020	79
AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer Chengfei Liu, Joy C. Yang, Cameron M. Armstrong, Molecular Cancer Therapeutics	2019	75
ABCB1 Mediates Cabazitaxel–Docetaxel Cross-Resistance in Advanced Prostate Cancer Alan P. Lombard, Chengfei Liu, Cameron M. Armstrong, Molecular Cancer Therapeutics	2017	71

Page 1